tradingkey.logo

OraSure Technologies Inc

OSUR

3.300USD

+0.010+0.30%
終値 09/18, 16:00ET15分遅れの株価
243.33M時価総額
損失額直近12ヶ月PER

OraSure Technologies Inc

3.300

+0.010+0.30%
詳細情報 OraSure Technologies Inc 企業名
OraSure Technologies, Inc. provides point-of-care and home diagnostic tests, sample management solutions, and microbiome laboratory and analytical services. The Company's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV and Hepatitis C that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Its business also includes molecular sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.
企業情報
企業コードOSUR
会社名OraSure Technologies Inc
上場日Nov 17, 1986
最高経営責任者「CEO」Ms. Carrie Eglinton Manner
従業員数501
証券種類Ordinary Share
決算期末Nov 17
本社所在地220 E First St
都市BETHLEHEM
証券取引所NASDAQ Global Select Consolidated
United States of America
郵便番号18015
電話番号15036416115
ウェブサイトhttps://www.orasure.com/
企業コードOSUR
上場日Nov 17, 1986
最高経営責任者「CEO」Ms. Carrie Eglinton Manner
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Kenneth J. (Ken) Mcgrath
Mr. Kenneth J. (Ken) Mcgrath
Chief Financial Officer
Chief Financial Officer
448.46K
-2.72%
Dr. Nancy J. Gagliano, M.D.
Dr. Nancy J. Gagliano, M.D.
Independent Director
Independent Director
158.15K
+72.80%
Mr. John P. Kenny
Mr. John P. Kenny
Independent Director
Independent Director
147.20K
+4.74%
Mr. Lelio Marmora
Mr. Lelio Marmora
Independent Director
Independent Director
130.76K
+93.09%
Hon Dr. David J. Shulkin, M.D.
Hon Dr. David J. Shulkin, M.D.
Independent Director
Independent Director
126.33K
+109.45%
Ms. Anne Messing
Ms. Anne Messing
Chief Commercial Officer
Chief Commercial Officer
--
--
Ms. Mara Glickman Aspinall
Ms. Mara Glickman Aspinall
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Robert W. Mcmahon
Mr. Robert W. Mcmahon
Independent Director
Independent Director
--
--
Mr. Jason Plagman
Mr. Jason Plagman
Vice President - Investor Relations
Vice President - Investor Relations
--
--
Ms. Carrie Eglinton Manner
Ms. Carrie Eglinton Manner
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Kenneth J. (Ken) Mcgrath
Mr. Kenneth J. (Ken) Mcgrath
Chief Financial Officer
Chief Financial Officer
448.46K
-2.72%
Dr. Nancy J. Gagliano, M.D.
Dr. Nancy J. Gagliano, M.D.
Independent Director
Independent Director
158.15K
+72.80%
Mr. John P. Kenny
Mr. John P. Kenny
Independent Director
Independent Director
147.20K
+4.74%
Mr. Lelio Marmora
Mr. Lelio Marmora
Independent Director
Independent Director
130.76K
+93.09%
Hon Dr. David J. Shulkin, M.D.
Hon Dr. David J. Shulkin, M.D.
Independent Director
Independent Director
126.33K
+109.45%
Ms. Anne Messing
Ms. Anne Messing
Chief Commercial Officer
Chief Commercial Officer
--
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Net product and services revenues - COVID-19
12.90M
43.10%
Net product and services revenues - HIV
9.11M
30.44%
Net product and service revenues -Molecular Products
4.33M
14.48%
Net product and services revenues - HCV
1.42M
4.74%
Other revenues - Other non Product revenues
934.00K
3.12%
他の
1.23M
4.12%
地域別USD
会社名
収益
比率
United States
20.34M
67.94%
Africa (Region)
7.19M
24.02%
Europe
1.64M
5.47%
Other Regions
770.00K
2.57%
事業別
地域別
事業別USD
会社名
収益
比率
Net product and services revenues - COVID-19
12.90M
43.10%
Net product and services revenues - HIV
9.11M
30.44%
Net product and service revenues -Molecular Products
4.33M
14.48%
Net product and services revenues - HCV
1.42M
4.74%
Other revenues - Other non Product revenues
934.00K
3.12%
他の
1.23M
4.12%
株主
更新時刻: Tue, Aug 19
更新時刻: Tue, Aug 19
株主統計
種類
株主統計
株主統計
比率
Private Management Group, Inc.
7.47%
BlackRock Institutional Trust Company, N.A.
7.43%
The Vanguard Group, Inc.
5.70%
Neuberger Berman, LLC
5.68%
Dimensional Fund Advisors, L.P.
5.25%
他の
68.47%
株主統計
株主統計
比率
Private Management Group, Inc.
7.47%
BlackRock Institutional Trust Company, N.A.
7.43%
The Vanguard Group, Inc.
5.70%
Neuberger Berman, LLC
5.68%
Dimensional Fund Advisors, L.P.
5.25%
他の
68.47%
種類
株主統計
比率
Investment Advisor
40.45%
Investment Advisor/Hedge Fund
27.75%
Hedge Fund
21.36%
Individual Investor
5.11%
Research Firm
2.36%
Pension Fund
0.44%
Bank and Trust
0.30%
Venture Capital
0.09%
Insurance Company
0.04%
他の
2.10%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
473
72.08M
98.55%
-16.70M
2025Q1
483
70.23M
93.78%
-12.52M
2024Q4
475
70.81M
94.94%
-10.37M
2024Q3
471
70.30M
94.28%
-10.80M
2024Q2
477
73.05M
98.74%
-8.54M
2024Q1
473
74.45M
97.36%
-5.59M
2023Q4
464
73.29M
99.74%
-5.62M
2023Q3
456
72.50M
98.73%
-4.51M
2023Q2
452
70.73M
96.51%
-2.77M
2023Q1
449
67.74M
89.31%
-3.74M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Private Management Group, Inc.
4.42M
5.91%
+4.42M
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
5.58M
7.45%
+27.48K
+0.50%
Mar 31, 2025
The Vanguard Group, Inc.
4.29M
5.73%
+60.97K
+1.44%
Mar 31, 2025
Neuberger Berman, LLC
4.28M
5.72%
+653.02K
+18.00%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
3.82M
5.11%
-147.56K
-3.72%
Mar 31, 2025
Renaissance Technologies LLC
2.57M
3.44%
-203.30K
-7.33%
Mar 31, 2025
Systematic Financial Management, L.P.
1.65M
2.2%
-26.46K
-1.58%
Mar 31, 2025
Acadian Asset Management LLC
2.76M
3.68%
-144.45K
-4.98%
Mar 31, 2025
American Century Investment Management, Inc.
2.51M
3.35%
+159.29K
+6.79%
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Sep 6
更新時刻: Sat, Sep 6
銘柄名
比率
Invesco NASDAQ Future Gen 200 ETF
0.5%
Lattice Hartford Multifactor Small Cap ETF
0.08%
Innovator US Small Cap Managed Floor ETF
0.03%
ProShares UltraPro Russell2000
0.01%
Proshares Ultra Russell 2000
0.01%
ETC 6 Meridian Small Cap Equity ETF
0%
SPDR S&P SmallCap 600 ESG ETF
0%
Inspire Fidelis Multi Factor ETF
0%
ETC 6 Meridian Low Beta Equity Strategy ETF
0%
DFA Dimensional US Core Equity Market ETF
0%
詳細を見る
Invesco NASDAQ Future Gen 200 ETF
比率0.5%
Lattice Hartford Multifactor Small Cap ETF
比率0.08%
Innovator US Small Cap Managed Floor ETF
比率0.03%
ProShares UltraPro Russell2000
比率0.01%
Proshares Ultra Russell 2000
比率0.01%
ETC 6 Meridian Small Cap Equity ETF
比率0%
SPDR S&P SmallCap 600 ESG ETF
比率0%
Inspire Fidelis Multi Factor ETF
比率0%
ETC 6 Meridian Low Beta Equity Strategy ETF
比率0%
DFA Dimensional US Core Equity Market ETF
比率0%
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI